P ROGRAM O N THE P HARMACEUTICAL I NDUSTRY MIT Sloan School of Management Cambridge, Massachusetts

Upcoming POPI Symposium

Past Symposia

2003 The Future of The Pharmaceutical Industry

December 9 - 10, 2003 Pharmacogenomics, Drug Development and the Cost of Health Care, A Special One-and-a-Half Day Program for Senior Corporate Management, Massachusetts Institute of Technology, Sloan School of Management, Tang Center, Wong Auditorium, Cambridge, Massachusetts
    New technologies are shifting the terrain of drug discovery and development.  The world of healthcare is undergoing the first part of a major revolution.  But will the tremendous advances in science and technology that have unfolded in recent years serve the goal of greater human health?  What are the key challenges and issues facing scientists and the pharmaceutical industry?  What might the future look like?

°     Symposium Brochure

°     Revised Agenda (as of November 5, 2003)

°     Guest Speakers

°    For more information about this event, click on post card or contact Abby Votto with your name, title, company, mailing address, telephone and fax to: (508) 616-5533 or e-mail to avotto@ibcusa.com.

°    Conference Registration

°    MIT Office of Corporate Relations/Industrial Liaison Program
        Attn:  Conference Planning
        292 Main Street, E38-500
        Cambridge, MA  02139
        For questions regarding your registration for this conference or up-to-the-minute information about this conference, please contact Diane Vrattos at (617) 253-0414 or send e-mail to: vrattos@ilp.mit.edu.

• If you do not have the free Adobe Acrobat Reader, click here

2001 The Future of The Pharmaceutical Industry

• December 13-14, 2001 Integrating New Drug Discovery & Development Technology with Complex Biological Systems Research, A Special One-and-a-Half Day Program for Senior Corporate Management, Cambridge, Massachusetts
      Scientific and technological advances are making information about cellular mechanisms of 
       disease available at an unprecedented rate.  How is this information being converted into
       therapeutic knowledge?  What are the implications for developing therapeutic solutions on a
       complex, biological, systems scale, for measuring drug effects and for predicting outcomes?
  °    Download Brochure
  °    Symposium Agenda

  • Updated Slide Presentations
    °    Anthony J. Sinskey, Sc.D. (Keynote Address)
    °    Terrence F. Blaschke, M.D., Ph.D.
    °    Klavs F. Jensen, Ph.D.
    °    Gavin MacBeath, Ph.D.
    °    Robert H. Rubin, M.D.
    °    Prof. Peter K. Sorger
    °    Suzanne Wait, Ph.D.

1999 The Future of The Pharmaceutical Industry

• A Special One-and-a-Half Day Program for Senior Corporate Management

December 13-14, 1999

• .pdf file Prof. Charles Cooney's Slide Presentation

1997 The Future of The Pharmaceutical Industry

For more information, comments, or suggestions contact popi-www@mit.edu
 

MIT Sloan School of Management